Abl2tm2.1Ajk
Targeted Allele Detail
|
|
| Symbol: |
Abl2tm2.1Ajk |
| Name: |
ABL proto-oncogene 2, non-receptor tyrosine kinase; targeted mutation 2.1, Anthony J Koleske |
| MGI ID: |
MGI:6369395 |
| Synonyms: |
abl2flox |
| Gene: |
Abl2 Location: Chr1:156386356-156477138 bp, + strand Genetic Position: Chr1, 67.71 cM
|
| Alliance: |
Abl2tm2.1Ajk page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:280257
|
| Parent Cell Line: |
J1 (ES Cell)
|
| Strain of Origin: |
129S4/SvJae
|
|
| Allele Type: |
|
Targeted (Conditional ready) |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: LoxP sites were inserted to flank exon 5. An adjacent loxP-flanked neomyvin selection cassette was removed via Cre-mediated recombination in ES cells prior to the production of chimeric mice.
(J:280257)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Abl2 Mutation: |
81 strains or lines available
|
|
| Original: |
J:280257 Kim SY, et al., Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies. Cell Death Differ. 2019 Mar;26(3):502-515 |
| All: |
1 reference(s) |
|